Ceftriaxone-induced toxic hepatitis

被引:19
作者
Peker, Erdal [1 ]
Cagan, Eren [1 ]
Dogan, Murat [1 ]
机构
[1] Med Univ Yuzuncu Yil, Dept Pediat, TR-65100 Van, Turkey
关键词
Hepatitis; Toxic; Ceftriaxone; Children; Drug; HEPATOTOXICITY;
D O I
10.3748/wjg.15.2669
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Toxic hepatitis or drug-induced liver injury encompasses a spectrum of clinical disease ranging from mild biochemical abnormalities to acute liver failure. The advantages of along half-life, wide spectrum, high tissue penetration rate, and a good safety profile, make ceftriaxone, a third-generation cephalosporin, a frequent choice in the treatment of childhood infections. Previous studies have reported a few cases of high aspartate aminotransferase and alanine aminotransferase levels, along with three cases of hepatitis caused by ceftriaxone. Here, we report a case of drug-induced toxic hepatitis in a patient who was treated with ceftriaxone for acute tonsillitis. (C) 2009 The WJG Press and Baishideng. All rights reserved.
引用
收藏
页码:2669 / 2671
页数:3
相关论文
共 9 条
[1]  
Bell Michael J, 2005, Pediatr Crit Care Med, V6, P363, DOI 10.1097/01.PCC.0000161285.12396.FF
[2]   Telithromycin-Associated Hepatotoxicity: Clinical Spectrum and Causality Assessment of 42 Cases [J].
Brinker, Allen D. ;
Wassel, Ronald T. ;
Lyndly, Jenna ;
Serrano, Jose ;
Avigan, Mark ;
Lee, William M. ;
Seeff, Leonard B. .
HEPATOLOGY, 2009, 49 (01) :250-257
[3]   Cefdinir-Induced Hepatotoxicity: Potential Hazards of Inappropriate Antibiotic Use [J].
Chen, Joy ;
Ahmad, Jawad .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 (11) :1914-1916
[4]   Pharmacogenomics of anti-TB drugs-related hepatotoxicity [J].
Das Roy, Puspita ;
Majumder, Mousumi ;
Roy, Bidyut .
PHARMACOGENOMICS, 2008, 9 (03) :311-321
[5]   Idiosyncratic drug-induced liver injury: an overview [J].
Hussaini, S. Hyder ;
Farrington, Elizabeth A. .
EXPERT OPINION ON DRUG SAFETY, 2007, 6 (06) :673-684
[6]  
Longo F, 1998, AM J GASTROENTEROL, V93, P836
[7]   LIFE-THREATENING COMPLICATIONS OF EMPIRIC CEFTRIAXONE THERAPY FOR SERONEGATIVE LYME-DISEASE [J].
NADELMAN, RB ;
ARLIN, Z ;
WORMSER, GP .
SOUTHERN MEDICAL JOURNAL, 1991, 84 (10) :1263-1264
[8]  
Polson Julie E, 2007, Clin Liver Dis, V11, P549, DOI 10.1016/j.cld.2007.06.009
[9]  
Robles M, 2008, REV ESP QUIM, V21, P224